CGA
AZN icon

Channing Global Advisors’s AstraZeneca AZN Stock Holding History

Channing Global Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34M Buy
181,599
+13,977
+8% +$2.63M 17.6% 1
2026
Q1 		$32.5M Buy
167,622
+162,281
+3,038% +$31.3M 18.99% 1
2025
Q4 		$982K Buy
5,341
+295
+6% +$51.7K 0.63% 26
2025
Q3 		$774K Buy
5,046
+184
+4% +$27.8K 0.54% 28
2025
Q2 		$680K Sell
4,862
-91
-2% -$12.8K 0.44% 31
2025
Q1 		$728K Sell
4,953
-163
-3% -$23.6K 0.5% 29
2024
Q4 		$670K Buy
5,116
+2,184
+74% +$306K 0.45% 32
2024
Q3 		$457K Sell
2,932
-342
-10% -$55.2K 0.39% 36
2024
Q2 		$511K Sell
3,274
-2
-0.1% -$301 0.43% 38
2024
Q1 		$444K Sell
3,276
-49
-1% -$6.49K 0.38% 36
2023
Q4 		$448K Sell
3,325
-423
-11% -$55K 0.35% 37
2023
Q3 		$508K Buy
3,748
+627
+20% +$85.6K 0.49% 35
2023
Q2 		$447K Buy
3,121
+173
+6% +$25.5K 0.45% 38
2023
Q1 		$409K Sell
2,948
-1,651
-36% -$222K 0.45% 35
2022
Q4 		$624K Sell
4,599
-164
-3% -$20.6K 0.72% 30
2022
Q3 		$522K Hold
4,763
– – 0.66% 29
2022
Q2 		$629K Sell
4,763
-267
-5% -$35K 0.68% 32
2022
Q1 		$667K Buy
5,030
+105
+2% +$12.6K 0.65% 29
2021
Q4 		$574K Buy
+4,925
New +$580K 0.54% 28

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

Channing Global Advisors's AZN Position: Q2 2026 in Review

Channing Global Advisors increased its AstraZeneca (AZN) stake by 8.3% in Q2 2026, buying an estimated $2.63M and bringing the position to 181,599 shares worth $34M. The position accounts for 17.6% of the portfolio, ranked #1.

Channing Global Advisors first reported a position in AZN in Q4 2021 and has held it in 19 quarters since. 612 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Channing Global Advisors held 181,599 shares of AstraZeneca worth $34M as of Q2 2026.
  • Channing Global Advisors bought 13,977 AstraZeneca shares in Q2 2026, an estimated $2.63M.
  • AstraZeneca made up 17.6% of Channing Global Advisors's portfolio in Q2 2026, its #1 holding.
  • Channing Global Advisors first reported a position in AstraZeneca in Q4 2021 and has held it in 19 quarters since.
  • 612 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Channing Global Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.